Clinical Trial Update: Prevention Trial of Nosocomial Infections in Neutropenic Prematures With G-CSF [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating granulocyte colony-stimulating factor (filgrastim) for prevention of nosocomial infections in neutropenic premature infants has compl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neonatal Neutropenia

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: University Hospital, Strasbourg, France | Conditions: Neutropenia in Prematures | Phase 3 | Status: COMPLETED